Indication

Gastrointestinal stromal tumor

A gastrointestinal stromal tumor is a rare mesenchymal neoplasm of the digestive tract that originates from the interstitial cells of Cajal or their precursors, which function as pacemaker cells regulating gastrointestinal motility. Read more about Gastrointestinal stromal tumor

11 drugs 11 manufacturers

Advertisement

Drugs that treat it

Common Gastrointestinal stromal tumor therapies.

Showing 1–9 of 11 drugs

STIVARGA (regorafenib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·METASTATIC COLORECTAL CANCER·+2
Bayer HealthCare

QINLOCK (ripretinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·GASTROINTESTINAL STROMAL TUMOR
DECIPHERA PHARM

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
Mylan Pharmaceuticals

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
AVKARE

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
DR.REDDY'S LAB

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
SUN PHARMACEUTI

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
AUROBINDO PHARM

SUNITINIB MALATE

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
NOVUGEN PHARMA
Filter & compare in the drug finder →Opens the drug finder with Gastrointestinal stromal tumor preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Gastrointestinal stromal tumor.

A gastrointestinal stromal tumor is a rare mesenchymal neoplasm of the digestive tract that originates from the interstitial cells of Cajal or their precursors, which function as pacemaker cells regulating gastrointestinal motility.

Although it can develop anywhere along the alimentary canal, it most commonly arises in the stomach and small intestine, predominantly affecting older adults.

Pathophysiologically, most cases are characterized by mutually exclusive gain-of-function mutations in the *KIT* or *PDGFRA* receptor tyrosine kinase genes, with a small subset driven by succinate dehydrogenase deficiency or other alterations.

Behavior ranges from indolent, small nodules to aggressive, highly metastatic sarcomas typically spreading to the liver and peritoneum.

Personalize your experience

Follow Gastrointestinal stromal tumor and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it